| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 0.0003 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |